What is the appropriate management for chlorpromazine toxicity?

Management of Chlorpromazine Toxicity

For chlorpromazine toxicity, provide aggressive supportive care with focus on airway protection, hemodynamic support, and management of anticholinergic and extrapyramidal symptoms—there are no specific antidotes, so treatment is entirely symptomatic and supportive.

Immediate Assessment and Stabilization

Airway and Respiratory Management

• Assess level of consciousness immediately using Glasgow Coma Scale
• CNS depression is the most common manifestation of chlorpromazine overdose 1
• Intubate if GCS < 9 or inability to protect airway 1
• In a case series of 218 chlorpromazine overdoses, 15% required endotracheal intubation, with median reported dose of 2,000 mg in intubated patients versus 1,200 mg in non-intubated patients 1
• For isolated chlorpromazine ingestions requiring intubation, the median dose was 2,500 mg (range: 1,800-20,000 mg) 1

Cardiovascular Monitoring and Support

• Monitor for hypotension from alpha-adrenergic blockade 2
• Chlorpromazine produces alpha-adrenergic blockade which can cause significant hypotension 2
• In overdose series, only 4% developed hypotension requiring intervention 1
• If hypotension occurs (SBP < 90 mmHg):
  • Start with IV crystalloid resuscitation
  • If refractory, use direct-acting vasopressors (norepinephrine preferred due to alpha-adrenergic blockade)
  • Avoid pure beta-agonists as alpha-blockade may worsen hypotension

Cardiac Monitoring

• Continuous cardiac monitoring for dysrhythmias
• Monitor for QT prolongation and torsades de pointes
• In the case series, dysrhythmias were uncommon but did occur 1
• Three patients (1.4%) developed seizures 1

Specific Toxicity Management

CNS Depression

• Primary concern is CNS depression leading to respiratory compromise
• 27% of overdose patients had GCS < 9 1
• 23% required ICU admission 1
• No reversal agents exist—management is purely supportive
• Maintain adequate oxygenation and ventilation

Anticholinergic Toxicity

• Chlorpromazine has significant anticholinergic properties 2, 3
• Look for anticholinergic syndrome: fever, tachycardia, tachypnea, delirium, mydriasis, dry mucous membranes, urinary retention, decreased bowel sounds
• One case report documented acute anticholinergic syndrome with 1,200 mg dose, manifesting as fever, increased pulse and respirations, and obtundation 3
• Physostigmine is generally NOT recommended due to risk of seizures and cardiac conduction abnormalities in the setting of phenothiazine toxicity
• Manage supportively with cooling for hyperthermia and benzodiazepines for agitation

Extrapyramidal Symptoms

• Acute dystonic reactions may occur even in overdose
• Treat with diphenhydramine 50 mg IV or benztropine 1-2 mg IV/IM

Delirium and Agitation

• 8% of overdose patients developed delirium 1
• Use benzodiazepines (lorazepam 1-2 mg IV) as first-line for agitation
• Avoid additional antipsychotics which may worsen toxicity

Decontamination Considerations

Activated Charcoal

• Consider if patient presents within 1-2 hours of ingestion AND can protect airway
• Dose: 1 g/kg (usual adult dose 50 g)
• Do NOT give if:
  • Altered mental status without protected airway
  • Risk of aspiration
  • Bowel obstruction or perforation

Gastric Lavage

• Generally NOT recommended unless massive, life-threatening ingestion within 1 hour
• Risk outweighs benefit in most cases

Enhanced Elimination

No role for hemodialysis, hemoperfusion, or urinary alkalinization—chlorpromazine is highly protein-bound and lipophilic 2

Monitoring and Disposition

Laboratory Monitoring

• Baseline: CBC, comprehensive metabolic panel, creatine kinase (for rhabdomyolysis risk), ECG
• Serial monitoring: Electrolytes, renal function if hypotensive
• No specific chlorpromazine levels guide management clinically

ICU Admission Criteria

• GCS < 9
• Hemodynamic instability requiring vasopressors
• Respiratory compromise requiring intubation
• Significant dysrhythmias
• Seizures
• Higher reported doses ingested correlate with ICU admission need (P < 0.0001) 1

Observation Period

• Minimum 6 hours observation for all intentional overdoses
• Extend to 12-24 hours if:
  • Reported dose > 1,000 mg
  • Any CNS depression
  • Co-ingestions present (occurred in 62% of cases) 1
• Most common co-ingestions: benzodiazepines, paracetamol, other antipsychotics 1

Critical Pitfalls to Avoid

1. Do NOT use flumazenil if benzodiazepine co-ingestion suspected—chlorpromazine lowers seizure threshold and flumazenil may precipitate seizures 2

2. Do NOT use epinephrine for hypotension—alpha-blockade will leave unopposed beta-agonism, potentially worsening hypotension

3. Do NOT assume safety with "therapeutic" doses—toxicity can occur at doses as low as 1,200 mg, especially under physiologic stress 3

4. Do NOT overlook anticholinergic syndrome—can be activated by psychological stress even at previously tolerated doses 3

5. Do NOT reduce anticonvulsant doses—chlorpromazine does not potentiate anticonvulsant effects and lowers seizure threshold 2

6. Do NOT miss co-ingestions—present in 62% of cases and significantly affect management 1

Consultation

Contact Poison Control Center (1-800-222-1222) or medical toxicologist for:

• All moderate to severe overdoses
• Uncertain ingestion amounts
• Polysubstance ingestions
• Refractory symptoms
• Guidance on disposition decisions

Prognosis

• Mortality is rare with appropriate supportive care—only 1 death in 218 cases (0.5%) 1
• Most patients recover fully with supportive management
• Duration of toxicity correlates with dose ingested
• Presentations have declined significantly since 2013 along with reported doses ingested 1